Shares of GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 1,547,523 shares.
GB Sciences Trading Down 17.8 %
GB Sciences Company Profile
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Recommended Stories
- Five stocks we like better than GB Sciences
- Why Are These Companies Considered Blue Chips?
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Best Aerospace Stocks Investing
- Price Targets on NVIDIA Rise in Front of Earnings
- How is Compound Interest Calculated?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
